spacer
home > epc > autumn 2003 > recruiting hiv infected patients for anti-retroviral clinical trials in cee and the russian federation
PUBLICATIONS
European Pharmaceutical Contractor

Recruiting HIV Infected Patients for Anti-Retroviral Clinical Trials in CEE and the Russian Federation

Over the past decade the number of international clinical trials performed in Central and Eastern Europe (CEE) has continuously increased. Amongst these countries, Poland has become a regular partner in the conduct of clinical trials although this is not yet the case for most other CEE countries. Since the start of the first trial in the Russian Federation only about 120 trials have been conducted there (1). However, given the positive aspects of performing clinical trials in CEE countries and the Russian Federation, one can expect the number of trials to increase over time. To explain, site staff tend to be very motivated and eager to participate in clinical trials, while the quality of work and ICH GCP compliance is largely impeccable. Even more important when conducting clinical trials, recruitment in CEE countries and the Russian Federation appears to be higher than in most Western European countries. This again is not only because of the motivated staff but also because of the availability of the potential trial population.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Stefan Comhaire, Project Manager at Medisearch International

Having begun his career in basic scientific research, Stefan Comhaire joined Medisearch International over five years ago. Starting in clinical research as a CRA, he is now a Project Manager in charge of setting up the collaboration with the CEE and the Russian Federation five years ago, during which he established long-lasting collaboration with Russian and Polish investigators. As a specialist in infectious diseases, he has led several clinical trials in HIV, most of them also recruiting in Eastern Europe and/or Russia.

spacer
Stefan Comhaire
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

AirBridgeCargo expands its passive pharma solutions in partnership with SkyCell as it achieves the two-fold volume increase

AirBridgeCargo expands its passive pharma solutions in partnership with SkyCell as it achieves the two-fold volume increase AirBridgeCargo Airlines (ABC), one of the leaders in transportation of pharmaceutical products by air, and Zurich-based cold-chain ULD manufacturer SkyCell have sealed their partnership for the lease of all types of SkyCell containers to meet the demand for evolving volumes of passive pharmaceutical shipments, which reached around 3,500 tonnes for 1Q 2019 YOY and demonstrated a two-fold increase.
More info >>

White Papers

A Rules Based Approach to Labelling and Artwork Management

Kallik

Many organisations today are experiencing unprecedented demands from regulatory authorities and consumers alike for product labelling to be made clearer and more informative. Forthcoming regulations (including the new EU MDR regulations coming into force May 2020) also require that labelling content to be published electronically in addition to print. As companies seek to continuously differentiate themselves in established markets as well as gain entry into new territories, the increase in both volume and complexity of product and market variations will have a direct impact on labelling.
More info >>

 
Industry Events

CPhI & P-MEC India

26-28 November 2019, India Expo Centre, Greater Noida, Delhi NCR, India

As the pharma industry looks increasingly towards India for high quality, low cost pharma solutions, CPhI & P-MEC India is the ideal event for companies wanting to pick up on the latest trends and innovations the market has to offer. At CPhI & P-MEC India, you will meet the movers and shakers from India's pharma machinery, technology and ingredients industries, giving you a competitive advantage that will help grow your business.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement